Name
GS1-11 - Sacituzumab Govitecan vs Treatment of Physician's Choice: Efficacy by Trop-2 Expression in the TROPiCS-02 Study of Patients With HR+/HER2- Metastatic Breast Cancer
Date & Time
Tuesday, December 6, 2022
Speakers
Virtual Session Link